Charles Greenberg to In Vitro Techniques
This is a "connection" page, showing publications Charles Greenberg has written about In Vitro Techniques.
Connection Strength
0.113
-
Regulation of human tissue transglutaminase function by magnesium-nucleotide complexes. Identification of distinct binding sites for Mg-GTP and Mg-ATP. J Biol Chem. 1998 Jan 16; 273(3):1776-81.
Score: 0.033
-
Thrombin binding to fibrin is necessary for fibrin polymers to enhance factor XIIIa formation. Semin Thromb Hemost. 1986 Jul; 12(3):226-7.
Score: 0.015
-
Regulation of thrombin cleavage of plasma factor XIII bound to fibrin. Ann N Y Acad Sci. 1986; 485:140-3.
Score: 0.014
-
Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting. J Clin Invest. 1985 May; 75(5):1463-70.
Score: 0.014
-
Measurement of blood coagulation Factor XIIIa formation in plasma containing glycyl-L-prolyl-L-arginyl-L-proline. Anal Biochem. 1985 Jan; 144(1):165-71.
Score: 0.013
-
Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models. Clin Cancer Res. 2000 Nov; 6(11):4359-64.
Score: 0.010
-
Assessments of thrombogenicity by three in vitro techniques. Student Research Award in the Undergraduate, Master Candidate, or Health Science Degree Candidate Category, 21st annual meeting of the Society for Biomaterials, San Francisco, CA, March 18-22, 1995. J Biomed Mater Res. 1995 Sep; 29(9):1039-45.
Score: 0.007
-
Cyclic GMP analogs inhibit gamma thrombin-induced arachidonic acid release in human platelets. Biochem Biophys Res Commun. 1989 Dec 15; 165(2):708-14.
Score: 0.005
-
Heparin-associated thrombocytopenia and thrombosis: a serious clinical problem and potential solution. J Vasc Surg. 1986 Nov; 4(5):522-8.
Score: 0.004